Titre:
  • Phase II study of necitumumab plus modified FOLFOX6 as first-line treatment in patients with locally advanced or metastatic colorectal cancer
Auteur:Elez, Elena; Hendlisz, Alain; Delaunoit, Thierry; Valera, Javier Sastre; Cervantes, Andrés; Varea, Rocio; Chao, Graceyi; Wallin, J.; Tabernero, Josep
Informations sur la publication:British Journal of Cancer, 114, 4, page (372-380)
Statut de publication:Publié, 2016-02
Sujet CREF:Cancérologie
Mots-clés:advanced colorectal cancer
EGFR
KRAS
modified FOLFOX6
necitumumab
Note générale:SCOPUS: ar.j
Langue:Anglais
Identificateurs:urn:issn:0007-0920
info:doi/10.1038/bjc.2015.480
info:scp/84954348380